» Articles » PMID: 23521884

A Molecular Basis for the Control of Preimmune Escape Variants by HIV-specific CD8+ T Cells

Abstract

The capacity of the immune system to adapt to rapidly evolving viruses is a primary feature of effective immunity, yet its molecular basis is unclear. Here, we investigated protective HIV-1-specific CD8+ T cell responses directed against the immunodominant p24 Gag-derived epitope KK10 (KRWIILGLNK263-272) presented by human leukocyte antigen (HLA)-B∗2705. We found that cross-reactive CD8+ T cell clonotypes were mobilized to counter the rapid emergence of HIV-1 variants that can directly affect T cell receptor (TCR) recognition. These newly recruited clonotypes expressed TCRs that engaged wild-type and mutant KK10 antigens with similar affinities and almost identical docking modes, thereby accounting for their antiviral efficacy in HLA-B∗2705+ individuals. A protective CD8+ T cell repertoire therefore encompasses the capacity to control TCR-accessible mutations, ultimately driving the development of more complex viral escape variants that disrupt antigen presentation.

Citing Articles

Recruitment of naive CD4+ T cells by the recombinant zoster vaccine correlates with persistent immunity.

Laing K, Ford E, Johnson M, Levin M, Koelle D, Weinberg A J Clin Invest. 2023; 133(23).

PMID: 37788096 PMC: 10688978. DOI: 10.1172/JCI172634.


Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide.

Li X, Singh N, Collins D, Ng R, Zhang A, Lamothe-Molina P Nat Commun. 2023; 14(1):2929.

PMID: 37217466 PMC: 10202051. DOI: 10.1038/s41467-023-38573-8.


Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study.

Titmuss E, Milne K, Jones M, Ng T, Topham J, Brown S Int J Mol Sci. 2023; 24(6).

PMID: 36982943 PMC: 10051648. DOI: 10.3390/ijms24065869.


SARS-CoV-2 variant biology: immune escape, transmission and fitness.

Carabelli A, Peacock T, Thorne L, Harvey W, Hughes J, Peacock S Nat Rev Microbiol. 2023; 21(3):162-177.

PMID: 36653446 PMC: 9847462. DOI: 10.1038/s41579-022-00841-7.


Homologous peptides derived from influenza A, B and C viruses induce variable CD8 T cell responses with cross-reactive potential.

Nguyen A, Lau H, Sloane H, Jayasinghe D, Mifsud N, Chatzileontiadou D Clin Transl Immunology. 2022; 11(10):e1422.

PMID: 36275878 PMC: 9581725. DOI: 10.1002/cti2.1422.